Author:
Donnell Deborah,Beesham Ivana,Welch Julia D,Heffron Renee,Pleaner Melanie,Kidoguchi Lara,Palanee-Phillips Thesla,Ahmed Khatija,Baron Deborah,Bukusi Elizabeth A,Louw Cheryl,Mastro Timothy D,Smit Jennifer,Batting Joanne R,Malahleha Mookho,Bailey Veronique C,Beksinska Mags,Rees Helen,Baeten Jared M,Gichangi Peter B,Heller Kate B,Mbandazayo Nomthandazo,Morrison Charles S,Nanda Kavita,Scoville Caitlin W,Shears Kathleen,Steyn Petrus S,Taylor Douglas,Thomas Katherine K,Kiarie James,Justman Jessica,Nhlabatsi Zelda,Bekker Linda-Gail,Nair Gonasagrie,Hofmeyr G Justus,Singata-Madliki Mandisa,Selepe Raesibe Agnes Pearl,Sibiya Sydney,Phiri Kasaro Margaret,Stringer Jeffrey,Mugo Nelly R
Funder
Bill and Melinda Gates Foundation
Subject
Virology,Infectious Diseases,Immunology,Epidemiology
Reference24 articles.
1. Guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects,2012
2. Preexposure prophylaxis for HIV infection among African women;Van Damme;N Engl J Med,2012
3. Tenofovir-based preexposure prophylaxis for HIV infection among African women;Marrazzo;N Engl J Med,2015
4. PrEP adherence and effect of drug level feedback among young African women in HPTN 082;Celum;J Int AIDS Soc,2019